Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

The article suggests using safety measures and telemedicine for aesthetic dermatology during COVID-19, while some procedures can still be done safely.

Certain genetic differences may affect how likely someone is to get COVID-19 and how severe it might be.

A woman's hair loss after COVID-19 was likely due to a mix of pressure-induced alopecia and acute telogen effluvium.

The treatment with an oral drug and topical lotion is effective and well-tolerated for hair loss after COVID-19.

Covid-19 can cause hair loss due to immune and psychological factors.

COVID-19 can cause hair loss, but specialists can help treat it.

Zinc acetate hydrate may help reduce fatigue and hair loss in post-COVID-19 patients.

COVID-19 may be linked to hair loss called Telogen Effluvium, affecting quality of life and self-esteem.

A woman lost over 80% of her hair due to a condition called telogen effluvium after having COVID-19.

COVID-19 leaves 80% of patients with long-term symptoms like fatigue and headaches.

Many COVID-19 survivors experience long-term symptoms but still report satisfactory quality of life and return to work.

Male pattern hair loss could hint at androgens affecting COVID-19 severity.

Some people who recover from COVID-19 continue to have symptoms like fatigue and cough for over 120 days, and some experience hair loss about 59 days after getting sick.

COVID-19 can cause various skin lesions, which may result from the virus and immune response, and are not directly linked to illness severity.

Insulin resistance linked to obesity may increase COVID-19 severity.

Androgenetic alopecia linked to COVID-19 severity; drugs reducing androgen receptor activation may help.

COVID-19 may cause hair loss due to infection stress or treatments.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

The COVID-19 pandemic led to an increase in untreated hair diseases and showed the importance of teledermatology.

5-alpha-reductase inhibitors may reduce COVID-19 symptoms in bald males.

AGA linked to worse COVID-19 outcomes in men.

Grey hair and baldness may be linked to COVID-19 severity, but more analysis is needed; post-infectious hair loss is related to the severity of the disease and usually recovers within 3-6 months.

Having a lot of gray hair and hair loss are linked to more severe COVID-19.

A certain genetic variant in the androgen receptor may predict the severity of COVID-19 in men.

Anabolic steroid users may face higher risk of severe COVID-19.

Non-Kuwaiti COVID-19 patients had worse health outcomes than Kuwaitis, likely due to poorer socioeconomic conditions.

A COVID-19 patient with severe hair loss did not improve with hair loss medication after stopping and restarting it due to the infection.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

Extra virgin olive oil may boost the immune system and help fight infections like COVID-19.